QQ客服 官方微博 反馈留言

	Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View
	Shi Hu; Shuaiyi Liang; Huaizu Guo; Dapeng Zhang; Hui Li; Xiaoze Wang; Weili Yang; Weizhu Qian; Sheng Hou; Hao Wang
刊名	Journal of Biological Chemistry
	2013
卷号	Vol.288 No.38页码:27059-27067
关键词	Antibodies Autoimmune Diseases Crystal Structure Protein Targeting Tumor Necrosis Factor (TNF) Adalimumab Epitope Mechanism
ISSN号	0021-9258
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1861937
专题	南开大学
作者单位	From the ‡Laboratory of Structural Biology and Ministry of Education Laboratory of Protein Science, School of Medicine, Tsinghua University, Beijing 100084, China, the §International Joint Cancer Institute, Second Military Medical University, Shanghai 200433, China, the ¶National Engineering Research Center for Antibody Medicine and Shanghai Key Laboratory of Cell Engineering & Antibody, Shanghai 201203, China, the ‖People's Liberation Army General Hospital Cancer Center, PLA Postgraduate School of Medicine, Beijing 100853, China, and the **School of Medicine, Nankai University, Tianjin 300071, China
推荐引用方式 GB/T 7714	Shi Hu,Shuaiyi Liang,Huaizu Guo,et al. Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View[J]. Journal of Biological Chemistry,2013,Vol.288 No.38:27059-27067.
APA	Shi Hu.,Shuaiyi Liang.,Huaizu Guo.,Dapeng Zhang.,Hui Li.,...&Zhiyong Lou.(2013).Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View.Journal of Biological Chemistry,Vol.288 No.38,27059-27067.
MLA	Shi Hu,et al."Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View".Journal of Biological Chemistry Vol.288 No.38(2013):27059-27067.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。